Related Experiment Video
Updated: Jan 26, 2026

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System
Published on: April 11, 2018
A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
Ben Sessa1, Laurie Higbed1, David Nutt1
1Neuropsychopharmacology Unit, Department of Medicine, Imperial College London, London, United Kingdom.
Abstract:
This paper provides a brief review of the history, proposed pharmacological mechanisms, safety issues, and clinical applications of the medicine 3,4-methylenedioxymethamphetamine (MDMA). Most clinical MDMA research in patients to date has focused on MDMA-assisted psychotherapy to treat posttraumatic stress disorder (PTSD). In this review paper other potential therapeutic applications for MDMA therapy are described, including contemporary studies treating anxiety associated with autism and the authors' ongoing study exploring the potential role for MDMA-assisted psychotherapy to treat alcohol use disorder. MDMA therapy for PTSD is now entering the final Phase 3 stage of drug development, with a target set for licensing by the FDA and EMA in 2021. This means that if clinical efficacy criteria are achieved, MDMA would become a medicine.
Insights
3,4-methylenedioxymethamphetamine (MDMA) therapy shows promise for treating posttraumatic stress disorder (PTSD) and other conditions. As MDMA-assisted psychotherapy nears FDA approval for PTSD, its potential as a novel medicine is expanding.
Area of Science:
- Psychopharmacology
- Neuroscience
- Clinical Psychology
Background:
- 3,4-methylenedioxymethamphetamine (MDMA) has a history of research into its effects.
- Current research focuses on MDMA-assisted psychotherapy for posttraumatic stress disorder (PTSD).
- MDMA therapy is progressing through late-stage clinical trials.
Purpose of the Study:
- To review the history, pharmacology, safety, and clinical applications of MDMA.
- To explore emerging therapeutic uses of MDMA beyond PTSD.
- To discuss the potential for MDMA to become an approved medicine.
Main Methods:
- Literature review of existing studies on MDMA.
- Analysis of proposed pharmacological mechanisms of MDMA.
- Examination of safety data and clinical trial outcomes.
Main Results:
- MDMA-assisted psychotherapy is a primary focus for PTSD treatment.
- Emerging research indicates potential therapeutic benefits for anxiety in autism spectrum disorder.
- Ongoing studies are investigating MDMA's role in treating alcohol use disorder.
Conclusions:
- MDMA therapy for PTSD is advancing to Phase 3 trials, with potential FDA and EMA licensing targeted for 2021.
- If efficacy criteria are met, MDMA could be approved as a prescription medicine.
- Further research is exploring MDMA's efficacy in other psychiatric conditions.
Related Concept Videos
Psychotherapy
Interpersonal Psychotherapy
Elements Crucial for Effective Psychotherapy
The Therapeutic Alliance
The therapeutic alliance refers to the relationship between the therapist and the client. The alliance strengthens when the therapist and the client engage in a nurturing, supportive, trusting, empathetic, and respectful relationship, improving therapeutic outcomes. Therapists must monitor this relationship...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Matrix-Assisted Laser Desorption Ionization (MALDI)

